FOXG1 holds the key to unlock brain disorders affecting millions, including autism, schizophrenia, brain tumors and many more.
Learn why FOXG1 is an excellent candidate for gene therapy and biotech investment.
Find out how FOXG1 could be a viable drug target for Autism and other disorders here.
FOXG1 Research Group is supported by the world-renowned BLACKSWAN Foundation in Switzerland.
We are funding leading neuroscientists and pioneering ground-breaking research on brain disorders.